Skip to main content
Premium Trial:

Request an Annual Quote

BGI Acquires 27 SOLiD 4 Systems from Life Tech

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BGI has acquired 27 SOLiD 4 instruments and will offer human genome sequencing on the platform under a partnership with Life Technologies announced today.

The acquisition will allow BGI, formerly called Beijing Genomics Institute, to sequence 50 whole genomes a month, they said in a joint statement.

Li Jingxiang, vice president of genomics operations for BGI, added that with the instruments, BGI will be able to generate sequencing data for a complete whole human genome at 30-fold coverage that includes 100 gigabases of mapped data at 99.9 percent accuracy.

Financial terms of the deal were not disclosed.

During Life Tech's third quarter earnings this week, the company reported record sales for the SOLiD 4 platform.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.